VWF antibody (AA 1815-1939)
Quick Overview for VWF antibody (AA 1815-1939) (ABIN6294346)
Target
See all VWF AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1815-1939
-
Purpose
- Rabbit anti-Human Recombinant von Willebrand Factor / vWFAntibody [IHC only]
-
Specificity
- Cytoplasmic
-
Purification
- Amino acids 1815-1939 from the human protein were used as the immunogen for this recombinant vWF antibody.
-
Immunogen
- Amino acids 1815-1939 from the human protein were used as the immunogen for this recombinant vWF antibody.
-
-
-
-
Application Notes
- Prediluted IHC only format: incubate for 30 min at RT (1)
-
Restrictions
- For Research Use only
-
-
-
Buffer
- Prediluted in 1X PBS, 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide, For IHC use only
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- 2-8°C. The azide-free format should be aliquoted and stored at -20°C or colder.
-
-
- VWF (Von Willebrand Factor (VWF))
-
Alternative Name
- von Willebrand factor ]
-
Background
-
Target Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen.
Gene Symbol: VWF///F8VWF
-
Gene ID
- 7450
-
UniProt
- P04275
Target
-